Methylphenidate Linked to Small Increase in CV Event Risk Methylphenidate Linked to Small Increase in CV Event Risk

Methylphenidate was associated with a small increased risk for cardiovascular events in individuals taking the drug for more than 6 months in a new cohort study.Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Cardiology Source Type: news